Abiopharma

News list

Greene John 🟢 acquired 13.0K shares (1 derivative) of CRISPR Therapeutics AG (CRSP) at $51.84 Transaction Date: Jun 05, 2026 | Filing ID: 264288

Full text

News bot June 9, 2026, 9:43 p.m.
🔍 Greene John (Executive)

Company: CRISPR Therapeutics AG (CRSP)

Report Date: 2026-06-05
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 13,000
Detailed Transactions and Holdings:
- Acquired 13,000 shares of Stock Option (Right to Buy) at $51.84 per share (Derivative)
  Date: 2026-06-05 | Code: A | Expires: 2036-06-05 | equity_swap_involved: false | shares_owned_after: 13,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on June 30, 2026 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2027 Annual Meeting.